한글목차

공황장애의 동향과 예측

세계의 공황장애 시장은 2024-2030년 CAGR 7.8%로 성장할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 공황장애로 이환하는 환자 수의 증가, 정신건강에 대한 인식과 구상의 증가입니다. 세계의 공황장애 시장의 미래는 병원, 멘탈 헬스케어 센터, 정신병원 시장에서의 비즈니스 기회에 의해 유망시되고 있습니다.

공황장애 시장 인사이트

Lucintel은 패닉 발작의 빈도와 중증도 경감에 도움이 되는 것으로 인해 정제가 계속해서 큰 부문을 차지할 것으로 예측하고 있습니다.

이 시장내에서 멘탈 헬스케어 센터는 개인 요법 및 그룹 요법, 투약 관리, 위기 개입 등 폭넓은 서비스를 제공하므로 최대 부문을 유지할 것으로 생각됩니다.

북미는 정신건강에 대한 의식의 향상과 고도로 발달한 헬스케어 인프라의 존재에 의해 예측 기간 중에도 최대 부문을 유지할 것으로 생각됩니다.

아래 11개의 주요 질문에 답변하고 있습니다. :

• Q.1.시장 부문 중 가장 유망하고 고성장인 기회는 무엇인가?
• Q.2.어느 부문이 보다 빠른 페이스로 성장하는가, 또 이유는?
• Q.3.향후 성장이 가속할 것으로 생각되는 지역과 이유는?
• Q.4.시장 역학에 영향을 미치는 주요 요인은 무엇인가? 시장에서 주요 과제와 비즈니스 리스크는?
• Q.5.이 시장에서 비즈니스 리스크와 경쟁의 위협은?
• Q.6.이 시장에서 새로운 동향과 이유는?
• Q.7.시장에서 고객의 수요 변화에는 어떤 것이 있는가?
• Q.8.이 시장에서 새로운 개발과 개발을 선도하고 있는 기업은?
• Q.9.이 시장의 주요 기업은? 주요 기업은 사업 성장을 위해 어떤 전략적 구상을 진행시키고 있는가?
• Q.10.이 시장에서의 경쟁 제품은 무엇이며, 재료 및 제품의 대체에 의한 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11.과거 5년간 어떤 M&A가 시행되고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 공황장애 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 2018-2030년의 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 공황장애 시장 동향(2018-2023)과 예측(2024-2030)
• 용량별 세계의 공황장애 시장
  • 정제
  • 주사
  • 기타
• 유형별 세계의 공황장애 시장
  • 광장 공포증
  • 사회불안장애
  • 강박장애
  • 조울증
  • 외상 후 스트레스 장애(PTSD)
  • 특정 공포증
  • 범불안장애
  • 주요우울장애
• 최종 용도별 세계의 공황장애 시장
  • 병원
  • 멘탈 헬스케어 센터
  • 정신병원
  • 기타

제4장 2018-2030년의 지역별 시장 동향과 예측 분석

• 지역별 세계의 공황장애 시장
• 북미의 공황장애 시장
• 유럽의 공황장애 시장
• 아시아태평양의 공황장애 시장
• 기타 지역의 공황장애 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 용량별 세계의 공황장애 시장의 성장 기회
  • 유형별 세계의 공황장애 시장의 성장 기회
  • 최종 용도별 세계의 공황장애 시장의 성장 기회
  • 지역별 세계의 공황장애 시장의 성장 기회
• 세계의 공황장애 시장의 새로운 동향
• 전략적 분석
  • 신제품의 개발
  • 세계의 공황장애 시장의 능력 확대
  • 세계의 공황장애 시장에서의 합병, 인수, 합병사업
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• Teva Pharmaceutical Industries
• Sun Pharmaceutical Industries
• Mylan
• AstraZeneca
• Abbott
• Baxter
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche
• GlaxoSmithKline

영문목차

Panic Disorders Trends and Forecast

The future of the global panic disorders market looks promising with opportunities in the hospitals, mental healthcare centres, and asylums markets. The global panic disorders market is expected to grow with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are increasing number of patients suffering from panic disorders and rising awareness and initiatives for mental health.

A more than 150-page report is developed to help in your business decisions.

Panic Disorders by Segment

The study includes a forecast for the global panic disorders by dosage, type, end use, and region.

Panic Disorders Market by Dosage [Shipment Analysis by Value from 2018 to 2030]:

• Tablets
• Injections
• Others

Panic Disorders Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Agoraphobia
• Social Anxiety Disorder
• Obsessive-Compulsive Disorder
• Bipolar Disorder
• Post-Traumatic Stress Disorder
• Specific Phobias
• Generalized Anxiety Disorder
• Major Depressive Disorder

Panic Disorders Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Mental Healthcare Centres
• Asylums
• Others

Panic Disorders Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Panic Disorders Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies panic disorders companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the panic disorders companies profiled in this report include-

• Teva Pharmaceutical Industries
• Sun Pharmaceutical Industries
• Mylan
• Astrazeneca
• Abbott
• Baxter
• Bristol-Myers Squibb Company
• Eli Lilly And Company
• F. Hoffmann-La Roche
• Glaxosmithkline

Panic Disorders Market Insights

Lucintel forecasts that tablets will remain the larger segment as it helps in reducing the frequency and severity of panic attacks.

Within this market, mental healthcare center will remain the largest segment as it delivers wide range of services, such as individual and group therapy, medication management, and crisis intervention.

North America will remain the largest segment over the forecast period due to rising awareness towards mental health and presence of highly developed healthcare infrastructure in the region.

Features of the Global Panic Disorders Market

Market Size Estimates: Panic disorders market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Panic disorders market size by dosage, type, end use, and region in terms of value ($B).

Regional Analysis: Panic disorders market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different dosage, types, end uses, and regions for the panic disorders market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the panic disorders market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for panic disorders market?

Answer: The global panic disorders market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the panic disorders market?

Answer: The major drivers for this market are increasing number of patients suffering from panic disorders and rising awareness and initiatives for mental health.

Q3. What are the major segments for panic disorders market?

Answer: The future of the panic disorders market looks promising with opportunities in the hospitals, mental healthcare centres, and asylums markets.

Q4. Who are the key panic disorders market companies?

Answer: Some of the key panic disorders companies are as follows:

• Teva Pharmaceutical Industries
• Sun Pharmaceutical Industries
• Mylan
• Astrazeneca
• Abbott
• Baxter
• Bristol-Myers Squibb Company
• Eli Lilly And Company
• F. Hoffmann-La Roche
• Glaxosmithkline

Q5. Which panic disorders market segment will be the largest in future?

Answer: Lucintel forecasts that tablets will remain the larger segment as it helps in reducing the frequency and severity of panic attacks.

Q6. In panic disorders market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to rising awareness towards mental health and presence of highly developed healthcare infrastructure in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the panic disorders market by dosage (tablets, injections, and others), type (agoraphobia, social anxiety disorder, obsessive-compulsive disorder, bipolar disorder, post-traumatic stress disorder, specific phobias, generalized anxiety disorder, and major depressive disorder), end use (hospitals, mental healthcare centres, asylums, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Panic Disorders Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Panic Disorders Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Panic Disorders Market by Dosage
  • 3.3.1: Tablets
  • 3.3.2: Injections
  • 3.3.3: Others
• 3.4: Global Panic Disorders Market by Type
  • 3.4.1: Agoraphobia
  • 3.4.2: Social Anxiety Disorder
  • 3.4.3: Obsessive-Compulsive Disorder
  • 3.4.4: Bipolar Disorder
  • 3.4.5: Post-Traumatic Stress Disorder
  • 3.4.6: Specific Phobias
  • 3.4.7: Generalized Anxiety Disorder
  • 3.4.8: Major Depressive Disorder
• 3.5: Global Panic Disorders Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Mental Healthcare Centres
  • 3.5.3: Asylums
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Panic Disorders Market by Region
• 4.2: North American Panic Disorders Market
  • 4.2.2: North American Panic Disorders Market by End Use: Hospitals, Mental Healthcare Centres, Asylums, and Others
• 4.3: European Panic Disorders Market
  • 4.3.1: European Panic Disorders Market by Dosage: Tablets, Injections, and Others
  • 4.3.2: European Panic Disorders Market by End Use: Hospitals, Mental Healthcare Centres, Asylums, and Others
• 4.4: APAC Panic Disorders Market
  • 4.4.1: APAC Panic Disorders Market by Dosage: Tablets, Injections, and Others
  • 4.4.2: APAC Panic Disorders Market by End Use: Hospitals, Mental Healthcare Centres, Asylums, and Others
• 4.5: ROW Panic Disorders Market
  • 4.5.1: ROW Panic Disorders Market by Dosage: Tablets, Injections, and Others
  • 4.5.2: ROW Panic Disorders Market by End Use: Hospitals, Mental Healthcare Centres, Asylums, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Panic Disorders Market by Dosage
  • 6.1.2: Growth Opportunities for the Global Panic Disorders Market by Type
  • 6.1.3: Growth Opportunities for the Global Panic Disorders Market by End Use
  • 6.1.4: Growth Opportunities for the Global Panic Disorders Market by Region
• 6.2: Emerging Trends in the Global Panic Disorders Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Panic Disorders Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Panic Disorders Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Teva Pharmaceutical Industries
• 7.2: Sun Pharmaceutical Industries
• 7.3: Mylan
• 7.4: AstraZeneca
• 7.5: Abbott
• 7.6: Baxter
• 7.7: Bristol-Myers Squibb Company
• 7.8: Eli Lilly and Company
• 7.9: F. Hoffmann-La Roche
• 7.10: GlaxoSmithKline